Weekly semaglutide improves blood sugar and weight in adults with type 1 diabetes, clinical trial finds

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who use automated insulin delivery systems.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup